KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) Operating Expenses (2017 - 2025)

Aurora Cannabis has reported Operating Expenses over the past 9 years, most recently at $19.4 million for Q4 2025.

  • Quarterly Operating Expenses rose 6.57% to $19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.7 million through Dec 2025, up 4.34% year-over-year, with the annual reading at $127.3 million for FY2025, 2.99% down from the prior year.
  • Operating Expenses was $19.4 million for Q4 2025 at Aurora Cannabis, down from $20.6 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $49.1 million in Q2 2021 and troughed at $17.2 million in Q3 2023.
  • The 5-year median for Operating Expenses is $20.9 million (2022), against an average of $24.8 million.
  • Year-over-year, Operating Expenses skyrocketed 355.99% in 2021 and then plummeted 58.64% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $48.4 million in 2021, then plummeted by 58.64% to $20.0 million in 2022, then dropped by 8.47% to $18.3 million in 2023, then dropped by 0.63% to $18.2 million in 2024, then increased by 6.57% to $19.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Operating Expenses are $19.4 million (Q4 2025), $20.6 million (Q3 2025), and $21.3 million (Q2 2025).